Luxembourg has been a donor to Gavi since 2005 and contributes to the Vaccine Alliance through direct contributions.
Luxembourg’s contribution is multi-year in support of Gavi’s model on predictable sustainable funding. Luxembourg made a first contribution of €4.7 million (US$ 6. 5 million) for the 2005–2010 period. In October 2010, Luxembourg signed a multi-year agreement for the period 2011–2015 for a total of €4.1 million (US$ 5.4 million). At Gavi’s replenishment conference in Berlin in 2015, Luxembourg pledged an additional €4.1 million (US$ 4.5 million) for the period 2016–2020.
On 4 June 2020, on the occasion of the Global Vaccine Summit, Prime Minister Xavier Bettel announced a 22% increase in support to Gavi, taking the annual commitment from Luxembourg to Gavi to €5 million (US$ 5.6 million) for the next five-year period. In addition, Luxembourg provided €5 million (US$ 5.6 million) to support the Gavi COVAX AMC.
During the African Vaccine Manufacturing Accelerator (AVMA) launch on 20 June 2024 in Paris, Luxembourg announced having strategically reallocated US$ 3 million of their COVID-19 funding to AVMA.
For Gavi 6.0, Luxembourg announced €5 million (US$ 5.8 million) in renewed resources and maintains its current level to Gavi despite increased fiscal pressure and a shrinking national ODA budget.
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: